Share on

Hair Loss Treatment Products Market - Segmentation by Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, Others), by End-Use (Homecare Settings, Dermatology Clinics), by Sales Channel (OTC, Prescription), and Segment Forecast 2022-2027

Published: January, 2022
ID: 9205
Pages: 175
Formats: report pdf report excel report power bi report ppt

Hair Loss Treatment Products Market Size (2022-2027):

The hair loss treatment products market was worth US$ xx million in 2021, and it is estimated to reach a valuation of US$ xx million by the end of 2026, expanding at a CAGR of 4.2% Hair Loss can be the result of a variety of malignant tumors resulting in thinning hair or baldness. This will lead to hair loss, especially among middle-aged and old-aged people.

Hair Loss Treatment Products Market Growth:

hair loss treatment products is growing at a rapid pace with significant growth in trichology centers in recent years, and the market is further likely to grow with more demand during the forecast period.

Hair Loss Treatment Products Market Drivers:

Hair loss is an essential issue for men and women around the world. Men suffer from alopecia for a long time due to androgenetic alopecia or general male baldness. However, in recent years, hair loss in women is increasing due to external factors such as environmental pollution and chemicals. Lifestyle changes, such as excessive intake of alcohol, tobacco, and related products, and increased stress levels, are considered powerful triggers for alopecia. The exact cause is unknown, but some cases are associated with genetic factors. Also, higher disposable income and greater emphasis on aesthetic appearance are supposed to contribute to the demand for hair loss treatment products. 

According to the American Academy of Dermatology, around 40% of women have visible hair loss when they are 40 years old. In most cases, women's hair loss affects their appearance and emotional well-being. Therefore, the American Hair Loss Association recognized that hair loss in women is a condition that changes dangerous lives that can no longer be ignored. Hormonal imbalances and diseases are the leading causes of hair loss. In such cases, hair loss often reverses naturally because the subject experiences unpredictable growth and shedding patterns. The main drivers of the market are changes in lifestyle patterns, the adoption of busy schedules that increase the level of stress, which leads to frequent hair loss in the early stages of the young population, higher disposable income, and greater emphasis on appearance.

Moreover, the increasing trichology clinics and advances in technology for the regrowth of hair, along with the wide range of products available in the market, are anticipated to result in tremendous growth opportunities for the market players in the next few years.

Hair Loss Treatment Products Market Restraints:

The presence of alternative treatment options for hair loss, such as hair transplant surgery, laser and phototherapy, and expensive drug costs will limit the market in the prognosis period.

HAIR LOSS TREATMENT PRODUCTS MARKET REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021–2026

Base Year

2021

Forecast Period

2022 - 2027

CAGR

4.2%

Segments Covered

  • According to the type of disease
  • By end-user
  • According to the sales channel
  • By Region 

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Histogen Inc., Concert Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Alès Groupe, Merck & Co., Inc., Alpecin, Vitabiotics Ltd., Sun Pharmaceutical Industries Ltd., Aclaris Therapeutics Inc., GlaxoSmithKline, Johnson and Johnson, Lifes2good, Daiichi Sankyo, Inc., Cipla and HCell Inc.

Market Segmentation:

Hair Loss Treatment Products Market According to the type of disease:

The Hair Loss Treatment Products Market has been divided into alopecia areata, cicatricial alopecia, traction alopecia, alopecia totalis, alopecia Universalis, androgenetic alopecia, and others. Alopecia areata led the market in 2018, representing more than 30% of product sales.

Hair Loss Treatment Products Market By end-user:

The dermatological clinic sector dominated the Hair Loss Treatment Products Market in 2018 and is foreseen to grow at a profitable pace during the forecast period. The worldwide increase in the number of hair restoration and transplant operations and the high use of prescription drugs are also a large part of the dermatology clinic.

Hair Loss Treatment Products Market According to the sales channel:

The market is divided into over counters (OTC) and prescription-based products. Prescription drug products led the market in 2018 and are presumed to continue leading by 2026. Corticosteroids and finasteride are some of the medications that are primarily prescribed for the treatment of alopecia.

Regional Analysis:

  • North America 
  • Europe
  • Asia Pacific 
  • Latin America
  • The Middle East and Africa 

North America has a large market for hair loss treatment and will dominate the business during the forecast period followed by Europe. According to the American Hair Loss Association, more than 80 million men and women suffer from hair loss problems in the United States alone. There are several beneficial initiatives taken by organizations such as NAAF and the American Hair Loss Association. According to Eurostat, the population of the European Union between 15 and 60 years is expected to decrease by 2060, and the population over 60 is expected to increase from 18% to 30%. Similarly, in the United States, population aging is expected to double by 2060, reaching 990 million. The increase in hair loss caused by aging has had a significant impact on market growth.

Key Players:

  1. Histogen Inc.
  2. Concert Pharmaceuticals Inc.
  3. Dr. Reddy's Laboratories Ltd.
  4. Alès Groupe, Merck & Co., Inc.
  5. Alpecin, Vitabiotics Ltd.
  6. Sun Pharmaceutical Industries Ltd.
  7. Aclaris Therapeutics Inc.
  8. GlaxoSmithKline
  9. Johnson and Johnson
  10. Lifes2good
  11. Daiichi Sankyo, Inc.
  12. Cipla and HCell Inc

Please wait. . . . Your request is being processed

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample